Published in Neuromuscul Disord on February 13, 2010
Targeting RNA to treat neuromuscular disease. Nat Rev Drug Discov (2011) 1.89
In-frame dystrophin following exon 51-skipping improves muscle pathology and function in the exon 52-deficient mdx mouse. Mol Ther (2010) 1.33
Restoration of the dystrophin-associated glycoprotein complex after exon skipping therapy in Duchenne muscular dystrophy. Mol Ther (2011) 1.30
Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials. Brain (2011) 1.17
Long-Term Efficacy, Safety, and Pharmacokinetics of Drisapersen in Duchenne Muscular Dystrophy: Results from an Open-Label Extension Study. PLoS One (2016) 1.06
Gene therapies that restore dystrophin expression for the treatment of Duchenne muscular dystrophy. Hum Genet (2016) 1.04
Mammalian models of Duchenne Muscular Dystrophy: pathological characteristics and therapeutic applications. J Biomed Biotechnol (2011) 1.02
Pharmacokinetics and safety of single doses of drisapersen in non-ambulant subjects with Duchenne muscular dystrophy: results of a double-blind randomized clinical trial. Neuromuscul Disord (2013) 0.91
Multiple exon skipping strategies to by-pass dystrophin mutations. Neuromuscul Disord (2011) 0.87
Personalized exon skipping strategies to address clustered non-deletion dystrophin mutations. Neuromuscul Disord (2010) 0.83
Animal models of muscular dystrophy. Prog Mol Biol Transl Sci (2012) 0.83
Whole dystrophin gene analysis by next-generation sequencing: a comprehensive genetic diagnosis of Duchenne and Becker muscular dystrophy. Mol Genet Genomics (2014) 0.81
Improving clinical trial design for Duchenne muscular dystrophy. BMC Neurol (2015) 0.81
Duchenne muscular dystrophy: current cell therapies. Ther Adv Neurol Disord (2015) 0.81
piggyBac transposons expressing full-length human dystrophin enable genetic correction of dystrophic mesoangioblasts. Nucleic Acids Res (2015) 0.79
Exon deletion pattern in duchene muscular dystrophy in north west of iran. Iran J Child Neurol (2015) 0.77
Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry (2004) 10.58
Infectivity of blood seropositive for hepatitis C virus antibodies. Lancet (1990) 4.99
Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature (1986) 4.13
Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications. Am J Hum Genet (1989) 3.81
Estimating Y chromosome specific microsatellite mutation frequencies using deep rooting pedigrees. Hum Mol Genet (1997) 3.78
BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat Genet (1997) 3.68
A deletion hot spot in the Duchenne muscular dystrophy gene. Genomics (1988) 3.18
Prenatal diagnosis and carrier detection of Duchenne muscular dystrophy with closely linked RFLPs. Lancet (1985) 3.08
Isolation of probes detecting restriction fragment length polymorphisms from X chromosome-specific libraries: potential use for diagnosis of Duchenne muscular dystrophy. Hum Genet (1985) 3.08
Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. Eur J Neurol (2010) 2.77
WHSC1, a 90 kb SET domain-containing gene, expressed in early development and homologous to a Drosophila dysmorphy gene maps in the Wolf-Hirschhorn syndrome critical region and is fused to IgH in t(4;14) multiple myeloma. Hum Mol Genet (1998) 2.77
EAA/EMQN best practice guidelines for molecular diagnosis of y-chromosomal microdeletions. State of the art 2004. Int J Androl (2004) 2.70
Array-CGH detection of micro rearrangements in mentally retarded individuals: clinical significance of imbalances present both in affected children and normal parents. J Med Genet (2005) 2.60
Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD). Neuromuscul Disord (2011) 2.47
Direct detection of more than 50% of the Duchenne muscular dystrophy mutations by field inversion gels. Nature (1987) 2.44
The PWWP domain: a potential protein-protein interaction domain in nuclear proteins influencing differentiation? FEBS Lett (2000) 2.24
The X chromosome shows less genetic variation at restriction sites than the autosomes. Am J Hum Genet (1986) 2.22
A physical map of 4 million bp around the Duchenne muscular dystrophy gene on the human X-chromosome. Cell (1986) 2.12
Protein truncation test (PTT) for rapid detection of translation-terminating mutations. Hum Mol Genet (1993) 2.08
Nine unknown rearrangements in 16p13.3 and 11p15.4 causing alpha- and beta-thalassaemia characterised by high resolution multiplex ligation-dependent probe amplification. J Med Genet (2005) 1.96
Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). Science (1990) 1.92
Two subsets of human alphoid repetitive DNA show distinct preferential localization in the pericentric regions of chromosomes 13, 18, and 21. Cytogenet Cell Genet (1986) 1.90
Long-range genomic map of the Duchenne muscular dystrophy (DMD) gene: isolation and use of J66 (DXS268), a distal intragenic marker. Genomics (1987) 1.89
Analysis of molecular variance (AMOVA) of Y-chromosome-specific microsatellites in two closely related human populations. Hum Mol Genet (1996) 1.84
Somatic APC mosaicism: an underestimated cause of polyposis coli. Gut (2007) 1.79
Efficient isolation of X chromosome-specific single-copy probes from a cosmid library of a human X/hamster hybrid-cell line: mapping of new probes close to the locus for X-linked mental retardation. Am J Hum Genet (1987) 1.77
Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells. Hum Mol Genet (2001) 1.76
Evidence for subtelomeric exchange of 3.3 kb tandemly repeated units between chromosomes 4q35 and 10q26: implications for genetic counselling and etiology of FSHD1. Hum Mol Genet (1996) 1.71
EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas. Am J Hum Genet (1999) 1.70
An extensive analysis of Y-chromosomal microsatellite haplotypes in globally dispersed human populations. Am J Hum Genet (2001) 1.70
Potentiometric polymeric membrane electrodes for measurement of environmental samples at trace levels: new requirements for selectivities and measuring protocols, and comparison with ICPMS. Anal Chem (2001) 1.70
Management of paraneoplastic neurological syndromes: report of an EFNS Task Force. Eur J Neurol (2006) 1.67
Identification of a hot spot for microdeletions in patients with X-linked deafness type 3 (DFN3) 900 kb proximal to the DFN3 gene POU3F4. Hum Mol Genet (1996) 1.67
Comparative analysis of antisense oligonucleotide sequences for targeted skipping of exon 51 during dystrophin pre-mRNA splicing in human muscle. Hum Gene Ther (2007) 1.63
Duplications in the DMD gene. Hum Mutat (2006) 1.58
DNA probe analysis for carrier detection and prenatal diagnosis of Duchenne muscular dystrophy: a standard diagnostic procedure. J Med Genet (1986) 1.55
Improved molecular diagnosis of dystrophinopathies in an unselected clinical cohort. Am J Med Genet A (2005) 1.54
Recommendations for locus-specific databases and their curation. Hum Mutat (2008) 1.49
Localization of the polymorphic human calcitonin gene on chromosome 11. Hum Genet (1984) 1.46
Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in The Netherlands: a cohort study. Lancet (1999) 1.46
Parental origin and germline mosaicism of deletions and duplications of the dystrophin gene: a European study. Hum Genet (1992) 1.44
Facioscapulohumeral muscular dystrophy in the Dutch population. Muscle Nerve Suppl (1995) 1.43
Complete allele information in the diagnosis of facioscapulohumeral muscular dystrophy by triple DNA analysis. Ann Neurol (2001) 1.42
Clinical characterisation of Becker muscular dystrophy patients predicts favourable outcome in exon-skipping therapy. J Neurol Neurosurg Psychiatry (2013) 1.42
Mutations in the EXT1 and EXT2 genes in hereditary multiple exostoses. Am J Hum Genet (1998) 1.39
[Turkish children with recurrent abdominal pain and fever: familial Mediterranean fever]. Ned Tijdschr Geneeskd (2003) 1.38
Development of additional RFLP probes near the locus for Duchenne muscular dystrophy by cosmid cloning of the DXS84 (754) locus. Hum Genet (1986) 1.38
Inter- and intrachromosomal sub-telomeric rearrangements on 4q35: implications for facioscapulohumeral muscular dystrophy (FSHD) aetiology and diagnosis. Hum Mol Genet (1998) 1.34
Patterns of serological markers in transfusion-transmitted hepatitis C virus infection using second-generation HCV assays. J Med Virol (1992) 1.33
The Dutch neuromuscular database CRAMP (Computer Registry of All Myopathies and Polyneuropathies): development and preliminary data. Neuromuscul Disord (2006) 1.33
Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy. Neuromuscul Disord (1999) 1.32
Comparative analysis of antisense oligonucleotide analogs for targeted DMD exon 46 skipping in muscle cells. Gene Ther (2004) 1.31
Calpainopathy-a survey of mutations and polymorphisms. Am J Hum Genet (1999) 1.31
Common pathological mechanisms in mouse models for muscular dystrophies. FASEB J (2005) 1.31
Fine mapping of the Huntington disease linked D4S10 locus by non-radioactive in situ hybridization. Hum Genet (1986) 1.30
Copy number variation in the genome; the human DMD gene as an example. Cytogenet Genome Res (2006) 1.29
Redefining the clinical phenotypes of non-dystrophic myotonic syndromes. J Neurol Neurosurg Psychiatry (2009) 1.29
Multipoint linkage analysis in X-linked ocular albinism of the Nettleship-Falls type. Hum Genet (1991) 1.29
Laboratory guidelines for molecular diagnosis of Y-chromosomal microdeletions. Int J Androl (1999) 1.27
Muscle regeneration in dystrophin-deficient mdx mice studied by gene expression profiling. BMC Genomics (2005) 1.23
Triggering of balance corrections and compensatory strategies in a patient with total leg proprioceptive loss. Exp Brain Res (2001) 1.23
Response mechanism of polymer membrane-based potentiometric polyion sensors. Anal Chem (1994) 1.22
Strict co-linearity of genetic and protein folding domains in an intragenically duplicated rat lens gamma-crystallin gene. J Mol Biol (1983) 1.21
Relative power and sample size analysis on gene expression profiling data. BMC Genomics (2009) 1.21
Different mosaicism frequencies for proximal and distal Duchenne muscular dystrophy (DMD) mutations indicate difference in etiology and recurrence risk. Am J Hum Genet (1992) 1.21
Structural variation in mammalian gamma-crystallins based on computer graphics analyses of human, rat and calf sequences. 1. Core packing and surface properties. Exp Eye Res (1986) 1.20
Dynamic mutation in Dutch Huntington's disease patients: increased paternal repeat instability extending to within the normal size range. J Med Genet (1993) 1.20
Determination of complex formation constants of lipophilic neutral ionophores in solvent polymeric membranes with segmented sandwich membranes. Anal Chem (1999) 1.19
Possible phenotypic dosage effect in patients compound heterozygous for FSHD-sized 4q35 alleles. Neurology (2003) 1.18
No protective effect of apolipoprotein E epsilon 2 allele in Dutch hereditary cerebral amyloid angiopathy. Ann Neurol (1995) 1.17
Recurrence risk due to germ line mosaicism: Duchenne and Becker muscular dystrophy. Clin Genet (2009) 1.17
The Lambert-Eaton myasthenic syndrome 1988-2008: a clinical picture in 97 patients. J Neuroimmunol (2008) 1.16
General description of the simultaneous response of potentiometric ionophore-based sensors to ions of different charge. Anal Chem (1999) 1.15
Prevalence of anti-HCV antibodies confirmed by recombinant immunoblot in different population subsets in The Netherlands. Vox Sang (1991) 1.15
High resolution deletion breakpoint mapping in the DMD gene by whole cosmid hybridization. Nucleic Acids Res (1989) 1.15
Two genes homologous with human protein S cDNA are located on chromosome 3. Thromb Haemost (1987) 1.14
Concerted and divergent evolution within the rat gamma-crystallin gene family. J Mol Biol (1986) 1.13
Cerebral microbleeds in CADASIL. Neurology (2001) 1.13
Characterization of SCML1, a new gene in Xp22, with homology to developmental polycomb genes. Genomics (1998) 1.11
Apparent gene conversions involving the SMN gene in the region of the spinal muscular atrophy locus on chromosome 5. Am J Hum Genet (1996) 1.10
Variation of CNV distribution in five different ethnic populations. Cytogenet Genome Res (2007) 1.10
Different positively charged amino acids have similar effects on the topology of a polytopic transmembrane protein in Escherichia coli. J Biol Chem (1992) 1.10
Hereditary frontotemporal dementia is linked to chromosome 17q21-q22: a genetic and clinicopathological study of three Dutch families. Ann Neurol (1997) 1.09
Protein truncation test (PTT) to rapidly screen the DMD gene for translation terminating mutations. Neuromuscul Disord (1994) 1.08
Detection of a new submicroscopic Norrie disease deletion interval with a novel DNA probe isolated by differential Alu PCR fingerprint cloning. Cytogenet Cell Genet (1993) 1.08
Polyion-sensitive membrane electrodes for biomedical analysis. Anal Chem (1996) 1.06